Evidence map›Paper›PMID 34812107›Full record

ArticleGut microbes

Aberrant enteric neuromuscular system and dysbiosis in amyotrophic lateral sclerosis.

Yongguo Zhang, Destiny Ogbu, Shari Garrett, Yinglin Xia, Jun Sun

Open access · goldAbstract read
In one paragraph

Article in Gut microbes. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 2 pooled it
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 2 syntheses or guidelines pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Systemic brain-body metabolic coupling patterns in amyotrophic lateral sclerosis: a whole-body [European journal of nuclear medicine and molecular imaging · 2026
    Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. TDP-43-mediated amyotrophic lateral sclerosis: new/hidden insights fromFrontiers in cell and developmental biology · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yongguo ZhangDepartment of Microbiology/Immunology, University of Illinois at Chicago, Chicago, USA.
Destiny OgbuDepartment of Microbiology/Immunology, University of Illinois at Chicago, Chicago, USA.
Shari GarrettDepartment of Microbiology/Immunology, University of Illinois at Chicago, Chicago, USA.
Yinglin XiaDepartment of Microbiology/Immunology, University of Illinois at Chicago, Chicago, USA.
Jun SunDepartment of Microbiology/Immunology, University of Illinois at Chicago, Chicago, USA.ORCID 0000-0001-7465-3133
University of Illinois Chicago · US

Funding

How Vitamin D Receptor Influences Intestinal BarriersR01DK114126 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI Jun Sun · 2018 to 2026
$3.0M
UIC Portal to Biomedical Research Careers (UIC PBRC) PREPR25GM121212 · NIGMS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI ALFONSO, AIXA, FEDERLE, MICHAEL J · 2018 to 2024
$1.8M
Vitamin D Receptor Regulation of Microbiota in Intestinal EpitheliaR01DK105118 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SUN, JUN · 2016 to 2020
$1.8M
Microbiome and intestinal barrier in ALS therapyI01BX004824 · VA · JESSE BROWN VA MEDICAL CENTER · PI SUN, JUN · 2020 to 2025
–
BLRD VA I01 BX004824NIDDK NIH HHS R01 DK105118NIDDK NIH HHS R01 DK114126NIGMS NIH HHS R25 GM121212
6 · The paper itself

Abstract

Amyotrophic Lateral Sclerosis is a neuromuscular disease characterized by the progressive death of motor neurons and muscle atrophy. The gastrointestinal symptoms in ALS patients were largely ignored or underestimated. The relationship between the enteric neuromuscular system and microbiome in ALS progression is unknown. We performed longitudinal studies on the enteric neuron system (ENS) and microbiome in the ALS human-SOD1

Indexed as

Amyotrophic Lateral SclerosisAnimalsAnti-Bacterial AgentsButyratesDisease Models, AnimalDysbiosisEnteric Nervous SystemGastrointestinal MicrobiomeGastrointestinal MotilityHumansIntestine, SmallLongitudinal StudiesMiceMice, TransgenicMuscle, SmoothMuscle StrengthAnti-Bacterial AgentsButyratesSOD1 G93A proteinSuperoxide DismutaseAutoimmune diseasebutyrate-producing bacteriacolonoidsenteric neuromuscular systemFALSLachnospiraceae bacterium A4neuromuscular diseaseprotein aggregationSALS

Identifiers

PMID34812107
PMCPMC8632307
OpenAlexW3217309048

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.